Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will present new data from its Alzheimer’s disease portfolio at the Alzheimer’s Association International ...
Five oral presentations in a Featured Research Session will highlight trontinemab, including new long-term data from Phase Ib ...
Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million ...
A chemical called 6PPD-quinone (6PPD-Q), which forms when shaved-off tire particles come into contact with ozone, might ...
The discovery of blood-based extracellular vesicles and particles carrying brain-specific information could help make ...
Healthy eating may help protect the brain, even after early biological changes linked to Alzheimer’s disease have begun, a ...
Researchers have identified a previously overlooked mechanism of brain cell death that appears to play a major role in ...
Memory loss is often treated like weather, something that arrives with age and cannot be stopped. But dementia does not fit ...
The mid-stage disappointment in Alzheimer’s disease delivers another blow to Neuphoria Therapeutics, which in November last year was forced to launch a strategic business review after a Phase 3 trial ...
A growing body of research suggests that the foods we eat may influence how well our brains age. While there is still no cure ...
The 79-year-old “Lethal Weapon” star told Lester Holt that he was diagnosed with the progressive neurodegenerative disease a ...
Research suggests diet remains a relevant factor for brain health even after blood markers of dementia are present.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results